Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sociodemographic disparities in COVID-19 seroprevalence across England in the Oxford RCGP primary care sentinel network.
Whitaker H, Tsang RSM, Button E, Andrews N, Byford R, Borrow R, Hobbs FDR, Brooks T, Howsam G, Brown K, Macartney J, Gower C, Okusi C, Hewson J, Sherlock J, Linley E, Tripathy M, Otter AD, Williams J, Tonge S, de Lusignan S, Amirthalingam G. Whitaker H, et al. Among authors: andrews n. J Infect. 2022 Jun;84(6):814-824. doi: 10.1016/j.jinf.2022.04.016. Epub 2022 Apr 9. J Infect. 2022. PMID: 35405169 Free PMC article.
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.
Burrage M, Robinson A, Borrow R, Andrews N, Southern J, Findlow J, Martin S, Thornton C, Goldblatt D, Corbel M, Sesardic D, Cartwight K, Richmond P, Miller E. Burrage M, et al. Among authors: andrews n. Infect Immun. 2002 Sep;70(9):4946-54. doi: 10.1128/IAI.70.9.4946-4954.2002. Infect Immun. 2002. PMID: 12183540 Free PMC article. Clinical Trial.
Comparison and correlation of neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.
Findlow J, Taylor S, Aase A, Horton R, Heyderman R, Southern J, Andrews N, Barchha R, Harrison E, Lowe A, Boxer E, Heaton C, Balmer P, Kaczmarski E, Oster P, Gorringe A, Borrow R, Miller E. Findlow J, et al. Among authors: andrews n. Infect Immun. 2006 Aug;74(8):4557-65. doi: 10.1128/IAI.00466-06. Infect Immun. 2006. PMID: 16861642 Free PMC article. Clinical Trial.
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.
Balmer P, Borrow R, Findlow J, Warrington R, Frankland S, Waight P, George R, Andrews N, Miller E. Balmer P, et al. Among authors: andrews n. Clin Vaccine Immunol. 2007 Nov;14(11):1442-50. doi: 10.1128/CVI.00264-07. Epub 2007 Sep 19. Clin Vaccine Immunol. 2007. PMID: 17881503 Free PMC article.
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom.
Southern J, Borrow R, Andrews N, Morris R, Waight P, Hudson M, Balmer P, Findlow H, Findlow J, Miller E. Southern J, et al. Among authors: andrews n. Clin Vaccine Immunol. 2009 Feb;16(2):194-9. doi: 10.1128/CVI.00420-08. Epub 2008 Dec 17. Clin Vaccine Immunol. 2009. PMID: 19091990 Free PMC article. Clinical Trial.
1,264 results